Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Christos N Papandreou"'
Publikováno v:
Frontiers in Oncology, Vol 5 (2015)
Neuroendocrine prostate carcinoma, either co-present with the local adenocarcinoma disease or as a result of transdifferentiation later in time, was described as one major process of emerging resistance to androgen deprivation therapies, and at the c
Externí odkaz:
https://doaj.org/article/97a08a8e7a714a499097b5326fcc57d8
Autor:
Panagiotis J. Vlachostergios, Konstantinos Dimitropoulos, Louis L. Pisters, Christos N. Papandreou, Danai Daliani, Anastasios Karatzas, Argiro Petsiti, Vassilios Tassoudis, Eleni Arnaoutoglou, Vassilios Tzortzis
Publikováno v:
Current Cancer Drug Targets. 23
Aim: Enhanced Recovery After Surgery (ERAS) protocols have been proven to optimize postoperative outcomes; however, misuse of opioid analgesics can still hinder postoperative recovery due to related side effects and potential complications. Introduct
Autor:
Panagiotis J. Vlachostergios, Athanasios Karathanasis, Christos N. Papandreou, Vassilios Tzortzis
Publikováno v:
World Journal of Oncology
Background Neuroendocrine differentiation (NED) of prostate cancer (PC) is a process that often occurs under evolutionary pressure from pharmacologic blockade of androgen receptor signaling at advanced stages of the disease. Identifying a subset of e
Autor:
Athanasios Kotsakis, Christos N. Papandreou, Ioannis Boukovinas, Vasiliki Michalaki, Christos Christodoulou, Vasiliki Sidiropoulou, Gerasimos Aravantinos, Antonios Avgerinos, Paris Kosmidis, Nikolaos Androulakis, Olga Kousidou
Publikováno v:
Anticancer Research. 40:435-441
AIM The purpose of the Imadje study was to confirm the efficacy and safety of imatinib, following resection of kit-positive gastrointestinal stromal tumour (GIST), in the adjuvant setting in the Greek population. PATIENTS AND METHODS A total of 34 ad
Autor:
Nikolaos Ziras, C. Kalofonos, Christos N. Papandreou, Pavlos Papakotoulas, Ioannis Boukovinas, Georgios Koumakis, Georgios Samelis, Helen Stergiou, Eleni Timotheadou, Evangelos Bournakis, Athina Christopoulou, Georgios Papatsimpas, Athanasios Athanasiadis, Gerasimos Aravantinos, Alexandros Bokas, Alexandros Ardavanis, Paris Makrantonakis, Ioannis Varthalitis, Maria Souggleri, Pavlos Papakostas, Epameinondas Samantas, Charalambos Andreadis, Nikolaos Tsoukalas, Anastasios Grivas, Sofia Tripodaki, Georgios Pentheroudakis
Publikováno v:
Anticancer Research. 40:305-313
Background Cancer-associated thrombosis (CAT), the second leading cause of death in patients with cancer can be treated with low molecular weight heparin (LMWH) according to guidelines. Patients and methods A multicenter prospective observational stu
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Autor:
Evangelos Bournakis, Athanasios Athanasiadis, Epameinondas Samantas, Gerasimos Aravantinos, Christos N. Papandreou, Georgios Samelis, Charalambos Andreadis, Maria Souggleri, Anastasios Grivas, Elli-Sofia Tripodaki, Georgios Koumakis, Nikolaos Ziras, Helen Stergiou, Eleni Timotheadou, Nikolaos Tsoukalas, Georgios Papatsimpas, Ioannis Varthalitis, Paris Makrantonakis, Alexandros Bokas, C. Kalofonos, Ioannis Boukovinas, Alexandros Ardavanis, Pavlos Papakostas, P. Papakotoulas, Athina Christopoulou, Georgios Pentheroudakis
Publikováno v:
Cancers, Vol 12, Iss 1907, p 1907 (2020)
Cancers
Volume 12
Issue 7
Cancers
Volume 12
Issue 7
Background: Cancer patients are at high risk for cancer-associated thrombosis (CAT). CAT is the second leading cause of death in these patients but it can be preventable with thromboprophylaxis. Patients and Methods: An observational, prospective, mu
Autor:
P. Papakotoulas, Athina Christopoulou, Nikolaos Tsoukalas, Alexandros Bokas, Athanasios Athanasiadis, Stavros D. Peroukidis, Alexandros Ardavanis, Achilleas Nikolakopoulos, Epaminontas Samantas, Nikolaos K. Kentepozidis, G. Anastopoulou, N. Kapodistrias, C. Andreadis, Ilias Athanasiadis, Eleni Timotheadou, D. Mavroudis, Anna Koumarianou, I. Boukovinas, Amanda Psyrri, V. Barbounis, Georgios Samelis, Christos N. Papandreou
Publikováno v:
Annals of Oncology. 32:S172
Autor:
Stavros D. Peroukidis, N. Kapodistrias, Alexandros Ardavanis, Achilleas Nikolakopoulos, Epaminondas Samantas, Barbounis Vassilios, Dimitrios Mavroudis, Ilias Athanasiadis, Nikolaos Tsoukalas, Christos N. Papandreou, Nikolaos K. Kentepozidis, Athanasios Athanasiadis, Anna Koumarianou, Ioannis Boukovinas, Georgios Samelis, C. Andreadis, Amanda Psyrri, P. Papakotoulas, Athina Christopoulou, Alexandros Bokas
Publikováno v:
Journal of Clinical Oncology. 39:e18803-e18803
e18803 Background: Cancer Associated Thrombosis (CAT) is an increasing challenge for oncology patients since oncologists sometimes are reluctant to mitigate the risk with thromboprophylaxis. Active cancer patients while receiving chemotherapy have a
Autor:
Vassilis Zaspalis, Eydokia Patrikiadou, Eleana Hatzidaki, Anna Patrikidou, Lori Nalbandian, Christos N. Papandreou
Publikováno v:
Current Nanoscience. 12:455-468
Autor:
N. Kapodistrias, D. Mavroudis, V. Barbounis, P. Papakotoulas, Alexandros Ardavanis, Athina Christopoulou, Anna Koumarianou, Athanasios Athanasiadis, Alexandros Bokas, I. Boukovinas, Georgios Samelis, Epaminontas Samantas, Christos N. Papandreou, Nikolaos K. Kentepozidis, Ilias Athanasiadis, C. Andreadis, H. P. Kalofonos, Stavros D. Peroukidis, Nikolaos Tsoukalas, A. Ligdas
Publikováno v:
Annals of Oncology. 31:S1052